Methotrexate for rheumatoid arthritis patients who are on hemodialysis

Rheumatology International

Volumn 31, Issue 12, 2011, Pages 1545-1547

  Al Hasani, Hasanein ^a   Roussou, Euthalia ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b KING GEORGE HOSPITAL   (United Kingdom)

Author keywords

End stage renal failure; Hemodialysis; Methotrexate; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; METHOTREXATE;

BULLOUS PEMPHIGOID; CROHN DISEASE; DISEASE SEVERITY; DRUG DISTRIBUTION; DRUG EFFICACY; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; KIDNEY AMYLOIDOSIS; KIDNEY FAILURE; KIDNEY TUBULE EXCRETION; NEPHROTOXICITY; PANCYTOPENIA; PRIORITY JOURNAL; PROTEINURIA; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; UREMIA;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BONE MARROW; HUMANS; KIDNEY FAILURE, CHRONIC; METHOTREXATE; PANCYTOPENIA; RENAL DIALYSIS; TUMOR NECROSIS FACTOR-ALPHA; WITHHOLDING TREATMENT;

EID: 83555165073     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2041-5     Document Type: Review

References (21)

1. WF Owen NL Lew Y Liu EG Lowrie 1993 The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis N Engl J Med 329 1001 1006 8366899 10.1056/NEJM199309303291404 (Pubitemid 23307908)
2. KK Cheung KM Chow CC Szeto MH Tai BC Kwan PK Li 2009 Fatal pancytopenia in a hemodialysis patient after treatment with low-dose methotrexate J Clin Rheumatol 15 4 177 180 19502905 10.1097/RHU.0b013e3181a61f2d
3. Janus N, Thariat J, Boulanger H, Deray G, Launay-Vacher V (2010) Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients. Ann Oncol 21(7):1395-1403
4. G Rosen B Caparros AG Huros C Kosloff A Nirenberg A Cacavio RC Marcove JM Lane B Mehta C Urban 1982 Preoperative chemotherapy for osteogenic sarcoma Cancer 49 1221 1230 6174200 10.1002/1097-0142(19820315)49:6<1221::AID- CNCR2820490625>3.0.CO;2-E 1:STN:280:DyaL387js1KgtA%3D%3D
5. FX Thierry I Vernier JM Dueymes H Roche P Canal F Meens JP Pourrat JJ Conte 1989 Acute renal failure after high dose MTX therapy Nephron 51 416 417 2918955 10.1159/000185335 1:STN:280:DyaL1M7ktlyltw%3D%3D
6. KR Hande JE Balow JC Drake 1977 Methotrexate and haemodalyisis Ann Intern Med 87 495 496 907253 1:STN:280:DyaE1c%2FhvVersg%3D%3D
7. CJ Diskin TJ Stokes LM Dansby L Radcliff TB Carter 2006 Removal of methotrexate by peritoneal dialysis and hemodialysis in a single patient with end-stage renal disease Am J Med Sci 332 3 156 158 16969149 10.1097/00000441- 200609000-00013 (Pubitemid 44401240)
8. Stoller RG, Kenneth RH, Jacobs SA, Rosenberg SA, Chabner BA (1977) Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity. New Engl J Med 297:630-634 (Pubitemid 8200049)
9. BG Feagan J Rochon, et al. 1995 Methotrexate for the treatment of Crohn's disease. The North American Crohn's study group investigations N Engl J Med 332 292 297 7816064 10.1056/NEJM199502023320503 1:STN:280:DyaK2M7hsFOitA%3D%3D
10. Basile C, Montanaro A, Semeraro A (2002) Should low-dose methotrexate therapy be prescribed to dialysis patients? Nephrol Dial Transpl 17(3):530-531 (Pubitemid 34211168)
11. Chess JA, Scholey G, Mikhail AI (2004) Neutropenia associated with the use of low-dose methotrexate in a peritoneal dialysis patient. Nephrol Dial Transpl 19(8):2158-2159 (Pubitemid 39139661)
12. S Gutierrez-Urena JF Molina CO Garcia ML Cuellar LR Espinoza 1996 Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis Arthritis Rheum 39 272 276 8849378 10.1002/art.1780390214 1:STN:280:DyaK287pslSisw%3D%3D (Pubitemid 26065267)
13. MH Ellman D Ginsberg 1990 Low dose methotrexate and severe neutropaenia in patients undergoing renal dialysis Arthritis Rheum 33 1060 1061 2369423 10.1002/art.1780330724 1:STN:280:DyaK3czhsV2rug%3D%3D (Pubitemid 20226364)
14. WW Clatham SL Morgan GS Alarcon 2000 Renal failure: a risk factor for methotrexate toxicity Arthritis Rheum 43 1185 1186 10.1002/1529-0131(200005)43: 5<1185::AID-ANR30>3.0.CO;2-V (Pubitemid 30368200)
15. Chester KA, Baker M, Mayer A (2005) Overcoming the immunologic response to foreign enzymes in cancer therapy. Expert Rev Clin Immunol 1(4):549-559
16. M Hammoudeh 2006 Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis Rheumatology (Oxford) 45 357 359 10.1093/ rheumatology/kei264 1:STN:280:DC%2BD287gt1Smug%3D%3D (Pubitemid 43372859)
17. JE Gottenberg F Merle-Vincent F Bentaberry Y Alanore F Berenbaum B Fautrel B Combe A Durbarch J Sibilia M Dougados X Mariette 2003 Anti tumour necrosis factor a therapy in 15 patients with AA amyloidosis secondary to inflammatory arthritides Arthritis Rheum 48 2019 2024 12847696 10.1002/art.11163 1:CAS:528:DC%2BD3sXmtFartbs%3D (Pubitemid 36828697)
18. O Elkayam PN Hawkins H Lachmann M Yaron D Caspi 2002 Rapid and complete resolution of proteinouria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab Arthritis Rheum 46 2571 2573 12384913 10.1002/art.10581 (Pubitemid 36118918)
19. AJ Hueber A Tunc G Schett B Manger 2007 Anti-tumour necrosis alpha therapy in patients with impaired renal function Ann Rheum Dis 66 981 982 10.1136/ard.2006.069211
20. I Nestorov 2005 Clinical pharmacokinetics of tumour necrosis factor antagonists J Rheumatol 32 74 13 18 (Pubitemid 40365775)
21. Singh R, Cuchacovich R, Huang W, Espinoza LR. (2002) Infliximab treatment in a patient with rheumatoid arthritis on hemodialysis. J Rheumatol 29 (3):636-637 (Pubitemid 34202840)